Contract R&D and Manufacturing Organization-Speed up development & market launching by specialized CRMO Service

Development

  • Products >
  • Development
The research institute in EuBiologics utilizes its specialized technologies and experiences in vaccine product development to develop the vaccines for bacterial epidemics, with the primary goal of health promotion of children in the developing countries.

After successfully launching its first product, Euvichol®, in the end of 2015, it has expedited its researches on new products, including preventative vaccines for new epidemics and bacterial vaccines for antibiotic resistance. It is anticipating new launches around 2020.
Product Overview (Development Finished)

Euvichol®, the first oral cholera
vaccine
developed in Korea.

View More

CRM197, immunological
protein (for research).

View More
Vaccine Product
Development
A vaccine pipeline to be developed with the specialized technologies and experiences in vaccine products. Diverse products are now in development. View More
상단으로